Factors Associated with Drug Consumption Without Scientific Evidence in Patients with Mild COVID-19 in Peru

• Autores: Soriano-Moreno, David R., Fernandez-Guzman, Daniel, Sangster-Carrasco, Lucero, Quispe-Vicuña, Carlos, Grados-Espinoza, Pamela, Ccami-Bernal, Fabricio, Morocho-Alburqueque, Noelia, Coba-Villan, Naomi, Velasquez-Fernandez, Randy, Nieto-Gutierrez, Wendy
• Formato: artículo
• Fecha de Publicación: 2022
• Institución: Universidad Peruana de Ciencias Aplicadas
• Repositorio: UPC-Institucional
• Lenguaje: inglés
• OAI Identifier: oai:repositorioacademico.upc.edu.pe:10757/668762
• Enlace del recurso: http://hdl.handle.net/10757/668762
• Nivel de acceso: acceso abierto
• Materia: antibiotic; associated factors (source: MESH); COVID-19; drug therapy; ivermectin; SARS-CoV-2

Objective This study aimed to evaluate the factors associated with the consumption of drugs without scientific evidence in patients with mild COVID-19 infection in Peru. Methods An analytical cross-sectional study was carried out including 372 adult patients with a history of mild COVID-19 disease. Factors associated with drug consumption were evaluated by Poisson regressions with robust variance adjustment using the bootstrapping resampling method. Results Seventy-two percent consumed some medication without scientific evidence, with antibiotics (71%) and ivermectin for human use (68%) being the most commonly used. Factors associated with the consumption of drugs to treat mild COVID-19 infection were thinking that the drugs are not effective (adjusted prevalence ratio, 0.55; 95% confidence interval, 0.41-0.74) and not being informed about the efficacy of the drugs (adjusted prevalence ratio, 0.48; 95% confidence interval, 0.36-0.65). Conclusions Education of the population seems to be the main factor that increases the consumption of drugs without scientific evidence in the Peruvian population to treat mild COVID-19.